BioWorld MedTech

Sep. 14, 2012

Financings roundup: iWalk raises $17 million for personal bionics platform

iWalk (Bedford, Massachusetts) has raised $17 million in a private Series D equity financing round led by Gilde Healthcare Partners. Geoff Pardo, partner at Gilde, has joined iWalk's board. Read More

Report from Israel: The time seems to be right for biomedical clustering in Israel

Sugar, sweat, yeast power new drug delivery device

Washington roundup: Sequestration may not affect device user fee sums in 2013

Agreements/contracts: UW, GE report investment in diagnostic imaging, radiology

Deal roundup: athenahealth to acquire Healthcare Data Services

Restructuring roundup: Ethicon in plan to add new $185M facility in Athens

Patent watch: Solta Medical and BTL resolve patent dispute

Product Briefs

People in the News

HIT roundup: NeoGenomics implements method for FISH test data

MDD's Diagnostic Extra

Today's news in brief

BioWorld

BioWorld briefs for May 21, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

WHO declares Ebola outbreak a public health emergency of international concern

BioWorld

The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...

Nxera Pharma prepares and tests new GPR17 antagonists

BioWorld Science

Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...